Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin To Target Arterial Events in Chronic Kidney Disease
2018-000644-26Phase 4Suspended
- Sponsor
- University of Southampton
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) and cardiac morbidity comparing Aspirin 75 mg with Placebo (2 arms). Primary endpoint: Time to first major vascular event. Started Feb 2019; status: suspended.
02
Drugs
aspirin
03
Conditions
chronic kidney disease (CKD)cardiac morbidity
Beyond the preview
Go deeper on 2018-000644-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000644-26.